SciSparc Stock Price

-0.01 (-0.39%)
Volume 1,900
Bid Price 2.59
Ask Price 2.65
News -
Day High


52 Week Range


Day Low
Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
Level 1 Starter
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
SciSparc Ltd SPRC NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.01 -0.39% 2.56 07:56:49
Open Price Low Price High Price Close Price Prev Close
Trades Volume Avg Volume 52 Week Range
20 1,900 - 1.80 - 7.08
Last Trade Time Type Quantity Stock Price Currency
08:00:01 24 $ 2.55 USD


Draw Mode:

SciSparc Ltd Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 8.17M 3.19M 3.18M $ - $ - -2.83 -0.80
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - - -

more financials information »

SciSparc News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical SPRC Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week2.132.752.012.48153,1790.4320.19%
1 Month3.263.63481.802.50126,856-0.70-21.47%
3 Months3.423.94991.803.09867,785-0.86-25.15%
6 Months7.007.001.803.34486,900-4.44-63.43%
1 Year7.007.081.803.35451,042-4.44-63.43%
3 Years7.007.081.803.35451,042-4.44-63.43%
5 Years7.007.081.803.35451,042-4.44-63.43%

SciSparc Description

SciSparc Ltd is a specialty clinical-stage pharmaceutical company. It is engaged in developing several immunotherapy products and it owns patents in the immunotherapy field. It is focused on creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. The company operates in the single segment of the Development of drugs based on cannabinoid molecules to be approved by an official regulatory authority.

Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.